What's New About New Psychoactive Substances?

被引：0
|
作者：
Pfeiffer-Gerschel, T. [1 ]
机构：
[1] IFT Inst Therapy Res Munich, Munich, Germany
来源：
GESUNDHEITSWESEN | 2015年 / 77卷
关键词：
D O I：
10.1055/s-0035-1563241
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] New Zealand's regulation of new psychoactive substances
    Newberry, Jack
    Wodak, Alex
    Sellman, Doug
    Robinson, Geoffrey
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2014, 348
  • [2] New psychoactive substances
    Krabseth, Hege M.
    Tuv, Silja S.
    Strand, Maren Cecilie
    Karinen, Ritva A.
    Wiik, Elisabeth
    Vevelstad, Merete S.
    Westin, Andreas Austgulen
    Oiestad, Elisabeth L.
    Vindenes, Vigdis
    [J]. TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2016, 136 (08) : 714 - 717
  • [3] New psychoactive substances
    Davidson, Colin
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2012, 39 (02): : 219 - 220
  • [4] New psychoactive substances: issues about the new approach from New Zealand government
    Lisia, von Diemen
    [J]. ADDICTION, 2014, 109 (10) : 1588 - 1589
  • [5] New psychoactive substances: Are there any good options for regulating new psychoactive substances?
    Reuter, Peter
    Pardo, Bryce
    [J]. INTERNATIONAL JOURNAL OF DRUG POLICY, 2017, 40 : 117 - 122
  • [6] The new psychoactive substances (NPS)
    Dargan, P. I.
    [J]. TOXICOLOGY LETTERS, 2019, 314 : S49 - S49
  • [7] PHARMACOLOGY OF NEW PSYCHOACTIVE SUBSTANCES
    Farre, M.
    Torrens, M.
    E, Papaseit
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2017, 121 : 21 - 21
  • [8] Controlling new psychoactive substances in New Zealand
    Johnson, C. S.
    Shadfar, Z.
    Allison, J. R.
    Walsh, K. A. J.
    Partington, H. K.
    [J]. AUSTRALIAN JOURNAL OF FORENSIC SCIENCES, 2023, 55 (05) : 670 - 688
  • [9] NEW PSYCHOACTIVE SUBSTANCES: THE NEW ZEALAND EXPERIENCE
    McCullough, Catherine
    [J]. DRUG AND ALCOHOL REVIEW, 2014, 33 : 46 - 46
  • [10] Benzofuries among the New Psychoactive Substances: a warning about cardiovascular risk
    Le Boisselier, R.
    Hamel-Senecal, L.
    Chretien, B.
    Lelong-Boulouard, V.
    Mallaret, M.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2019, 33 : 83 - 83
12345